Related Experiment Videos
[Multiple Sclerosis Functional Composite Measure (MSFC) standardized in the Brazilian population]
Charles P Tilbery1, Maria Fernanda Mendes, Rodrigo Barbosa Thomaz
1Centro de Atendimento e Tratamento da Esclerose Múltipla, Faculdade de Ciências Médicas, Santa Casa de São Paulo, São Paulo, SP, Brazil. charlespt@einstein.br
Arquivos De Neuro-Psiquiatria
|April 15, 2005
Summary
The Multiple Sclerosis Functional Composite Measure (MSFC) is a three-part clinical assessment for multiple sclerosis. This study standardized the MSFC for use in Brazilian multiple sclerosis centers.
Area of Science:
- Neurology
- Clinical Assessment
- Neuroscience
Context:
- Multiple Sclerosis (MS) significantly impacts individuals, necessitating robust outcome measures.
- The Multiple Sclerosis Functional Composite Measure (MSFC) was developed to capture the multifaceted effects of MS.
- Standardization is crucial for consistent application across different clinical settings.
Purpose:
- To adapt and standardize the Multiple Sclerosis Functional Composite Measure (MSFC) for the Brazilian population.
- To validate the MSFC as a reliable outcome measure in Brazilian multiple sclerosis centers.
- To ensure the MSFC accurately reflects the principal ways MS affects individuals in a Brazilian context.
Summary:
- The study involved 91 Brazilian subjects undergoing the MSFC, comprising the 9-Hole Peg Test, Timed 25-Foot Walk, and PASAT.
- The MSFC was successfully applied and standardized, demonstrating its suitability for use in Brazilian MS centers.
- The findings support the MSFC's utility as a multidimensional tool for assessing multiple sclerosis progression.
Impact:
- Facilitates consistent and comparable assessment of multiple sclerosis patients across Brazilian healthcare facilities.
- Enhances clinical research and patient monitoring by providing a standardized outcome measure.
- Contributes to improved understanding and management of multiple sclerosis in Brazil.